Amsterdam UMC, location VUmc: clinical-trial pipeline
Amsterdam UMC, location VUmc is the sponsor of 304 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 71 are not yet finished and 4 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 207 |
| Phase 4 | 36 |
| Phase 2 | 19 |
| Phase 1 | 13 |
| Phase 3 | 12 |
| Phase 1/2 | 9 |
| Phase 2/3 | 6 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 129 |
| Unknown | 82 |
| Recruiting | 44 |
| Terminated | 19 |
| Not yet recruiting | 17 |
| Active, not recruiting | 10 |
| Withdrawn or not authorised | 2 |
| Suspended or halted | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 94 |
| Cardiovascular | 51 |
| Neurology | 30 |
| Metabolic and endocrine (diabetes, obesity) | 29 |
| Nephrology and urology | 23 |
| Gastroenterology and liver | 22 |
| Psychiatry and mental health | 16 |
| Respiratory | 15 |
| Infectious disease and vaccines | 11 |
| Rare and genetic diseases | 9 |
| Musculoskeletal | 8 |
| Ophthalmology | 6 |
Countries
| Country | Trials |
|---|---|
| Netherlands | 279 |
| Germany | 9 |
| United Kingdom | 7 |
| Denmark | 6 |
| Spain | 4 |
| Finland | 4 |
| France | 4 |
| Norway | 3 |
| Belgium | 2 |
| Italy | 2 |
| Poland | 2 |
| Portugal | 2 |
| Sweden | 2 |
| Australia | 1 |
| Canada | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-07 | New trial posted | ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metast… |
| 2026-09-29 | New trial posted | Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer |
| 2026-09-01 | New trial posted | Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer |
| 2026-08-28 | New trial posted | Back on Track: Evaluation of an Occupational Reintegration Protocol for Employees With Mu… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06384560 | Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5) | Phase 1/2 | Recruiting | Netherlands |
| NCT06457789 | Assessment of PET Tracers to Evaluate T Cell Change and Activation in Relation to Immunotherapy Treatment Res… | Not applicable | Recruiting | Netherlands |
| NCT04225312 | Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis | Phase 4 | Active, not recruiting | Netherlands |
| NCT06687876 | Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemo… | Phase 2 | Recruiting | Netherlands |
| NCT05957250 | [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct C… | Not applicable | Recruiting | Netherlands |
| NCT04392037 | Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone | Phase 2 | Active, not recruiting | Netherlands |
| NCT05861505 | COLLISION RELAPSE Trial | Phase 3 | Recruiting | Netherlands |
| NCT02371304 | Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Vers… | Phase 3 | Recruiting | France, Netherlands |
| NCT04307953 | Saracatinib Trial TO Prevent FOP | Phase 2 | Active, not recruiting | Germany, United Kingdom, Netherlands |
| NCT06658522 | Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluat… | Phase 4 | Not yet recruiting | Netherlands |
| NCT07781722 | Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis | Phase 4 | Recruiting | Netherlands |
| NCT07615881 | Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in… | Phase 1/2 | Not yet recruiting | |
| NCT05834855 | Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS | Phase 3 | Recruiting | Netherlands |
| NCT06623565 | Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques | Not applicable | Recruiting | Netherlands |
| NCT05088785 | Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer | Not applicable | Active, not recruiting | Netherlands |
| NCT06824961 | Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilat… | Not applicable | Recruiting | Netherlands |
| NCT07278206 | Brain Stimulation in Long COVID | Not applicable | Recruiting | Netherlands |
| NCT06282562 | FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients | Not applicable | Recruiting | Netherlands |
| NCT07863336 | ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer | Not applicable | Not yet recruiting | |
| NCT06298695 | Schema Therapy for Treatment-resistant Anxiety Disorders | Not applicable | Not yet recruiting | |
| NCT07155681 | Evaluating Healthcare Professionals' Satisfaction and Stress Mitigation Using Virtual Reality Intervention in… | Not applicable | Not yet recruiting | Germany, Denmark |
| NCT04815928 | Registry of Patients That Have Undergone ICA or PCI | Not applicable | Recruiting | Netherlands |
| NCT06185556 | COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascu… | Phase 2/3 | Recruiting | Netherlands |
| NCT05296161 | B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis | Phase 4 | Active, not recruiting | Netherlands |
| NCT06731361 | Improved Prescribing for Older Nursing Home Patients | Not applicable | Recruiting | Netherlands |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Amsterdam UMC, location VUmc clinical trials: 71 open, 18 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/amsterdam-umc-location-vumc/, data as of 2026-10-25.